Synthesis, characterization, and anti-tumor activities of some transition metal(II) complexes with podophyllic acid hydrazide

[1] Ayres, D. C., & Loike, J. D. (1990). Lignans: chemical, biological and clinical properties. London: Cambridge University Press. 10.1017/CBO9780511983665Search in Google Scholar

[2] Bekheit, M. M., & Ibrahim, K. M. (1986). Synthesis of some transition metal complexes derived from 1-valeroyl-4-phenyl-3-thiosemicarbazide. Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry, 16, 1135.1147. DOI: 10.1080/00945718608071387. http://dx.doi.org/10.1080/0094571860807138710.1080/00945718608071387Search in Google Scholar

[3] Biradar, N. S., & Locker, A. L. (1974). Complexes of zirconyl chloride with schiff bases containing ONS sequences. Journal of Inorganic and Nuclear Chemistry, 36, 1915–1916. DOI: 10.1016/0022-1902(74)80540-3. http://dx.doi.org/10.1016/0022-1902(74)80540-310.1016/0022-1902(74)80540-3Search in Google Scholar

[4] Canel, C., Moraes, R. M., Dayan, F. E., & Ferreira, D. (2000). Podophyllotoxin. Phytochemistry, 54, 115–120. DOI: 10.1016/S0031-9422(00)00094-7. http://dx.doi.org/10.1016/S0031-9422(00)00094-710.1016/S0031-9422(00)00094-7Search in Google Scholar

[5] Cardillo, B., Giorgini, E., Maurelli, E., & Tosi, G. (1992). Molecular complexes of hydrazides with copper(II). Monatshefte für Chemie, 123, 231–236. DOI: 10.1007/BF00810470. http://dx.doi.org/10.1007/BF0081047010.1007/BF00810470Search in Google Scholar

[6] Chen, Y. Z., Zhang, C. J., & Tian, X. (1987). Spin-labeled antitumor derivatives of podophyllotoxin. Scientia Sinica — Series B: Chemical, Biological, Agricultural, Medical and Earth Sciences, 30, 1070–1079. Search in Google Scholar

[7] Cho, S. J., Tropsha, A., Sufness, M., Cheng, Y. C., & Lee, K. H. (1996). Three-dimensional quantitative structure-activity relationship study of 4′-O-demethylepipodophyllotoxin analogs using the modified CoMFA/q2-GRS approach. Journal of Medicinal Chemistry, 39, 1383–1395. DOI: 10.1021/jm9503052. http://dx.doi.org/10.1021/jm950305210.1021/jm9503052Search in Google Scholar

[8] Cortese, F., Bhattacharyya, B., & Wolff, J. (1977). Podophyllotoxin as a probe for the colchicine binding site of tubulin. Journal of Biological Chemistry, 252, 1134–1140. 10.1016/S0021-9258(17)40631-4Search in Google Scholar

[9] Damayanthi, Y., & Lown, J. W. (1998). Podophyllotoxins: current status and recent developments. Current Medicinal Chemistry, 5, 205–252. 10.2174/0929867305666220314204426Search in Google Scholar

[10] Dodoff, N., Grancharov, K., & Spassovska, N. (1995). Platinum(II) complexes of 4-methoxy- and 4-chlorobenzoic acid hydrazides. Synthesis, characterization, and cytotoxic effect. Journal of Inorganic Biochemistry, 60, 257–266. DOI: 10.1016/0162-0134(95)00025-9. http://dx.doi.org/10.1016/0162-0134(95)00025-910.1016/0162-0134(95)00025-9Search in Google Scholar

[11] Empt, U., Alfermann, A. W., Pras, N., & Petersen, M. (2000). The use of plant cell cultures for the production of podophyllotoxin and related lignans. Journal of Applied Botany, 74, 145–150. Search in Google Scholar

[12] Fridborg, K., Kannan, K. K., Liljas, A., Lundin, J., Strandberg, B., Strandberg, B., Tilander, B. (The Late), & Wiren, G. (1967). Crystal structure of human erythrocyte carbonic anhydrase C. III. Molecular structure of the enzyme and of one enzyme-inhibitor complex at 5.5 Å resolution. Journal of Molecular Biology, 25, 505–516. DOI: 10.1016/0022-2836(67)90202-1. http://dx.doi.org/10.1016/0022-2836(67)90202-110.1016/0022-2836(67)90202-1Search in Google Scholar

[13] Geary, W. J. (1971). The use of conductivity measurements in organic solvents for the characterisation of coordination compounds. Coordination Chemistry Reviews, 7, 81–122. DOI: 10.1016/S0010-8545(00)80009-0. http://dx.doi.org/10.1016/S0010-8545(00)80009-010.1016/S0010-8545(00)80009-0Search in Google Scholar

[14] Giri, A., & Narasu, M. L. (2000). Production of podophyllotoxin from Podophyllum hexandrum: a potential natural product for clinically useful anticancer drugs. Cytotechnology, 34, 17–26. DOI: 10.1023/A:1008138230896. http://dx.doi.org/10.1023/A:100813823089610.1023/A:1008138230896Search in Google Scholar

[15] Gordaliza, M., Castro, M. A., Miguel, D. C. J. M., & Feliciano, A. S. (2000). Antitumor properties of podophyllotoxin and related compounds. Current Pharmaceutical Design, 6, 1811–1839. DOI: 10.2174/1381612003398582. http://dx.doi.org/10.2174/138161200339858210.2174/1381612003398582Search in Google Scholar

[16] Hande, K. R. (1998). Etoposide: four decades of development of a topoisomerase II inhibitor. European Journal of Cancer, 34, 1514–1521. DOI: 10.1016/S0959-8049(98)00228-7. http://dx.doi.org/10.1016/S0959-8049(98)00228-710.1016/S0959-8049(98)00228-7Search in Google Scholar

[17] Hughes, M. N. (1972). The inorganic chemistry of biological processes. London: Wiley. Search in Google Scholar

[18] Imbert, T. F. (1998). Discovery of podophyllotoxins. Biochimie, 80, 207–222. DOI: 10.1016/S0300-9084(98)80004-7. http://dx.doi.org/10.1016/S0300-9084(98)80004-710.1016/S0300-9084(98)80004-7Search in Google Scholar

[19] Issell, B. F. (1982). The podophyllotoxin derivatives VP16-213 and VM26. Cancer Chemotherapy and Pharmacology, 7, 73–80. DOI: 10.1007/BF00254525. 10.1007/BF00254525Search in Google Scholar

[20] Jardine, I. (1980). Anticancer agents based on natural products models. New York: Academic Press. Search in Google Scholar

[21] Kadow, J. F., Vyas, D. M., & Doyle, T. W. (1989). Synthesis of etoposide lactam via a mitsunobu reaction sequence. Tetrahedron Letters, 30, 3299–3302. DOI: 10.1016/S0040-4039(00)99226-8. http://dx.doi.org/10.1016/S0040-4039(00)99226-810.1016/S0040-4039(00)99226-8Search in Google Scholar

[22] Loike, J. D., Brewer, C. F., Sternlicht, H., Gensler, W. J., & Horwitz, S. B. (1978). Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners. Cancer Research, 38, 2688–2693. DOI: 0008-5472/78/0038-0000502.00. Search in Google Scholar

[23] Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55–63. DOI: 10.1016/0022-1759(83)90303-4. http://dx.doi.org/10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4Search in Google Scholar

[24] Muhi-Eldeen, Z., Al-Obaidi, K., Nadir, M., & Roche, V. F. (1992). Synthesis and antimicrobial activity of Ni(II), Co(II), Zn(II) and Cd(II) complexes of 4-substituted-3-mercapto- 5-phenyl-4H-1,2,4-triazoles. European Journal of Medicinal Chemistry, 27, 101–106. DOI: 10.1016/0223-5234(92)90097-K. http://dx.doi.org/10.1016/0223-5234(92)90097-K10.1016/0223-5234(92)90097-KSearch in Google Scholar

[25] Narang, K. K., & Singh, V. P. (1993). Synthesis, characterization, thermal studies and biological activity of Iron(III) complexes with some acylhydrazines. Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry, 23, 971–989. DOI: 10.1080/15533179308016876. http://dx.doi.org/10.1080/1553317930801687610.1080/15533179308016876Search in Google Scholar

[26] Rutschmann, J., & Renz, J. (1959). Über saurehydrazide aus der podophyllotoxin-reihe. 8. mitteilung über mitosehemmende naturstoffe. Helvetica Chimica Acta, 42, 890.907. DOI: 10.1002/hlca.19590420334. http://dx.doi.org/10.1002/hlca.1959042033410.1002/hlca.19590420334Search in Google Scholar

[27] Sackett, D. L. (1993). Podophyllotoxin, steganacin and combretastatin: Natural products that bind at the colchicine site of tubulin. Pharmacology & Therapeutics, 59, 163–228. DOI: 10.1016/0163-7258(93)90044-E. http://dx.doi.org/10.1016/0163-7258(93)90044-E10.1016/0163-7258(93)90044-ESearch in Google Scholar

[28] Schacter, L. (1996). Etoposide phosphate: what, why, where, and how? Seminars in Oncology, 3, 1–7. Search in Google Scholar

[29] Schrecker, A. W., & Hartwell, J. L. (1956). Components of podophyllin. XX. The absolute configuration of podophyllotoxin and related lignans. Journal of Organic Chemistry, 21, 381–382. DOI: 10.1021/jo01109a617. 10.1021/jo01109a617Search in Google Scholar

[30] Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the National Cancer Institute, 82, 1107–1112. DOI: 10.1093/jnci/82.13.1107. http://dx.doi.org/10.1093/jnci/82.13.110710.1093/jnci/82.13.1107Search in Google Scholar

[31] Stähelin, H. F., & von Wartburg, A. (1991). The chemical and biological route from podophyllotoxin glucoside to etoposide: Ninth Cain Memorial Award lecture. Cancer Research, 51, 5–15. Search in Google Scholar

[32] Sur, P., Chatterjee, S. P., Roy, P., & Sur, B. (1995). 5-Nitrofuran derivatives of fatty acid hydrazides induce differentiation in human myeloid leukaemic cell lines. Cancer Letters, 94, 27–32. DOI: 10.1016/0304-3835(95)03819-I. http://dx.doi.org/10.1016/0304-3835(95)03819-I10.1016/0304-3835(95)03819-ISearch in Google Scholar

[33] Ter, H. E., Rosenkranz, H. S., Hamel, E., & Day, B. W. (1996). Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents. Bioorganic & Medicinal Chemistry, 4, 1659–1671. DOI: 10.1016/0968-0896(96)00158-7. http://dx.doi.org/10.1016/0968-0896(96)00158-710.1016/0968-0896(96)00158-7Search in Google Scholar

[34] Tian, X., Zhang, F. M., & Li, W. G. (2002). Antitumor and antioxidant activity of spin labeled derivatives of podophyllotoxin (GP-1) and congeners. Life Sciences, 70, 2433–2443. DOI: 10.1016/S0024-3205(02)01482-0. http://dx.doi.org/10.1016/S0024-3205(02)01482-010.1016/S0024-3205(02)01482-0Search in Google Scholar

[35] Wang, P. H., Zhang, Q., Wang, L. F., Song, Y. M., Qu, J. Q., & Liu, Y. Q. (2006). Studies on the interaction of the metal complex of hydrazide of podophyllic acid with DNA. Spectroscopy and Spectral Analysis, 26, 941–943. Search in Google Scholar

[36] Ward, R. S. (1999). Lignans, neolignans and related compounds. Natural Product Reports, 16, 75–96. DOI: 10.1039/a705992b. http://dx.doi.org/10.1039/a705992b10.1039/a705992bSearch in Google Scholar

[37] Witterland, A. H. I., Koks, C. H. W., & Beijnen, J. H. (1996). Etoposide phosphate, the water soluble prodrug of etoposide. Pharmacy World & Science, 18, 163–170. DOI: 10.1007/BF00820727. http://dx.doi.org/10.1007/BF0082072710.1007/BF00820727Search in Google Scholar PubMed

[38] Yu, J. (2001). An experimental study on proliferative and apoptotic effects of podophyllic acid in K562 cells. Ph.M. thesis, Lanzhou Medical College, Lanzhou. Search in Google Scholar